Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Cough, Dyspnoea, Pain, Pyrexia
Clinical narrative: 4th dose - 12Apr2022, lot number 001M21A; He also had aching body; He has a cough and a runny nose; His breathing was a little worse than normal/it is his breathing that is concerning him; He has a cough and a runny nose; His temperature was slightly high; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (He also had aching body), COUGH (He has a cough and a runny nose), DYSPNOEA (His breathing was a little worse than normal/it is his breathing that is concerning him), RHINORRHOEA (He has a cough and a runny nose) and PYREXIA (His temperature was slightly high) in a 62-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:COPD.  The patient's past medical history included COPD. Previously administered products included for Drug use for unknown indication: Moderna (1st dose: lot number 025J20-2A) on 09-Jan-2021, Moderna (2nd dose -lot number 012M20A) on 11-Feb-2021, Moderna (3rd dose-Lot number 049E21A) on 04-Nov-2021, Spikevax (4th dose- Lot number 001M21A) on 12-Apr-2022, Moderna (5th dose-lot number was unknown) on 17-Nov-2022 and Flu vaccine. Past adverse reactions to the above products included No adverse reaction with Flu vaccine, Moderna, Moderna, Moderna, Moderna and Spikevax. Concomitant products included PREDNISONE for an unknown indication.    On 29-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 02-Nov-2023, the patient experienced PAIN (He also had aching body). 02-Nov-2023, the patient experienced COUGH (He has a cough and a runny nose), DYSPNOEA (His breathing was a little worse than normal/it is his breathing that is concerning him), RHINORRHOEA (He has a cough and a runny nose) and PYREXIA (His temperature was slightly high). On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (4th dose - 12Apr2022, lot number 001M21A). At the time of the report, PAIN (He also had aching body), COUGH (He has a cough and a runny nose), DYSPNOEA (His breathing was a little worse than normal/it is his breathing that is concerning him), RHINORRHOEA (He has a cough and a runny nose) and PYREXIA (His temperature was slightly high) was resolving and WRONG PRODUCT ADMINISTERED (4th dose - 12Apr2022, lot number 001M21A) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: Slightly high (100 degrees)..     For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-748628, US-MODERNATX, INC.-MOD-2023-748631, US-MODERNATX, INC.-MOD-2023-748624 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-748628:Wife Case (Monovalent) US-MODERNATX, INC.-MOD-2023-748631:Wife Case (Bivalent)